The latest cancer drugs news
Browsing: Cancer Drug News
ESMO 2017: Abemaciclib Initial Therapy Improves Outcome in Endocrine-sensitive Advanced Breast Cancer
The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid,…
New way of predicting kidney function could improve chemotherapy dosing for many cancer patients
Scientists at the University of Cambridge have developed a new statistical model which estimates kidney…
Time since chemotherapy may predict response to olaparib in ovarian cancer
Women with advanced ovarian cancer who begin treatment with olaparib are more likely to respond…
EHA: Cerdulatinib demonstrates rapid tumour responses in a phase 2 study for relapsed/refractory NHL
Cerdulatinib is an oral, dual Syk-JAK inhibitor with a unique mechanism of action. It inhibits…
Identifying similarities between next-generation prostate cancer drugs
Researchers have shown for the first time how a class of advanced prostate cancer drugs…
How to reduce expenditure on injectable cancer drugs
By Peter Gilbar for oncologynews.com.au The Problem Spending on cancer drugs is increasing at a…
Cancer Research in Space: NASA Cancer Drug Investigation
On Earth, research into antibody-drug conjugates to treat cancer has been around a while. The…
New three-in-one blood test opens door to precision medicine for prostate cancer
Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer…
Peter Mac scientists open new window on how drugs work in the body
Research led by Peter Mac has found a way to map, in unprecedented detail, all…
My Top 3 ASCO Abstracts by Prunella Blinman
Prospective pooled analysis of six phase III trials investigating duration of adjuvant oxaliplatin-based therapy (3…